Health Care/Hospital
Asieris Announces Approval of its Phase III Trial of a Novel Single Oral Agent as First-line Treatment for Non-Muscle Invasive Bladder Cancer (NMIBC)
SHANGHAI, Nov. 5, 2020 /PRNewswire/ -- Asieris Pharmaceuticals (Asieris), a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, recently announced that the Center for Drug Evaluation (CDE) ...
2020-11-05 13:59
1413
Gracell Biotechnologies Announces Two Oral Presentations at the ASH Annual Meeting and Exposition 2020
SUZHOU and SHANGHAI, China, Nov. 4, 2020 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced two oral presentations at the...
2020-11-05 11:52
1388
Samsung Biologics' Virtual Exhibition Hall earns top industry award for digital creativity and innovation
INCHEON, South Korea, Oct. 4, 2020 /PRNewswire/ -- Samsung Biologics' Virtual Exhibition Hall was recently recognized for its highly interactive digital capabilities and virtual reality (VR) technology to connect with clients around the world. The company's experiential platform won the Best Digi...
2020-11-04 20:00
1814
Daddybaby Protective Masks Certified by BSI, Contributing to the Prevention and Control of the Global Pandemic
FUZHOU, China, Nov. 3, 2020 /PRNewswire/ -- With the global pandemic not showing any signs of abating, medical protective supplies such as masks and protective clothing are still in high demand around the world. Recently, protective masks by Daddybaby Co., Ltd. ("Daddybaby") were certified by the...
2020-11-03 20:15
1175
Dazhou, China: No Family or Person Left behind on Way out of Poverty to Well-off Life
CHENGDU, China, Nov. 3, 2020 /PRNewswire/ -- A task team of the Dazhou Disabled Persons' Federation (DDPF), together with multiple medical rehabilitation institutions, spent their time fromOct. 19 to 21, in Wanyuan, Dazhou, providing the locals with disabilities (PWDs) with "Express Medical Servi...
2020-11-03 15:14
1150
Great Bay Bio Announces Its First AI-enabled Bioprocessing Platform-Klone 4.0, Reducing Cell Line Development Time and Cost by Up to 80%
HONG KONG, Nov. 2, 2020 /PRNewswire/ -- Klone 4.0 accomplishes both in a manner that could potentially disrupt the bioprocessing industry, firstly by reducing development times by up to 80% as AI eliminates many of the laboratory pain points through GBB's proprietary deep machine learning techniq...
2020-11-02 22:00
1324
Senhwa Announces Multiple IND application submissions to U.S. FDA for Silmitasertib as a Potential Treatment for COVID-19
TAIPEI and SAN DIEGO, Nov. 2, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc.
(TPEx: 6492), a clinical-stage biopharmaceutical company focused on
next-generation DNA Damage Response (DDR) therapeutics for the treatment of
cancer, today announced that it has submitted an Investigational New Drug
2020-11-02 22:00
1767
CARsgen Therapeutics Closes a USD 186 Million Series C Equity Financing to Accelerate Global Clinical Trials of its Cell Therapy Product Candidates
SHANGHAI, Nov. 2, 2020 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited ("CARsgen"), a leading biotechnology company focused on innovation and development of chimeric antigen receptor (CAR) T-cell therapeutics, today announced the completion of aUSD 186 million Series C Equity Financing. The...
2020-11-02 19:00
3659
Saudi Commission for Health Specialties® and Prometric® Open Innovative Testing Center in Riyadh
Forward-looking design provides unparalleled access, security, and service quality BALTIMORE, Nov. 2, 2020 /PRNewswire/ -- The Saudi Commission for Health Specialties (SCFHS), in collaboration with Prometric, has opened a new professional testing center inRiyadh, Saudi Arabia. This hallmark me...
2020-11-02 13:05
1472
Samsung Biologics Establishes Partnership with China Biotech GeneQuantum Healthcare to Collaborate on ADC Development
INCHEON, South Korea and SUZHOU, China, Nov. 1, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into a strategic partnership with GeneQuantum Healthcare, a China biotech company, to jointly develop an antibody drug conjugate (ADC) for the treatment of non-small-cell lung carcinoma ...
2020-11-02 08:27
1450
TaiGen Announces FDA Approval of IND for Its Flu Antiviral TG-1000
TAIPEI, Taiwan, Nov. 1, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") (Taiwan: 4157) announced today that U.S. Food and Drug Administration ("FDA") has approved the Investigation New Drug (IND) application for TG-1000, a novel treatment for influenza A and B. TG-1000 is a...
2020-11-02 07:30
1318
PolyActiva appoints Tracy Valorie, ophthalmic industry expert and former Bausch + Lomb executive, to its Board of Directors
MELBOURNE, Australia, Oct. 30, 2020 /PRNewswire/ -- PolyActiva Pty Ltd, a clinical-stage ophthalmology biopharmaceutical company, today announced the appointment of highly experienced ophthalmic industry expert,Tracy Valorie, as a new member to the company's Board of Directors. Ms Valorie is rec...
2020-10-30 20:00
1928
Support reaching out both physicians and the community: SonoScape in Germany
SHENZHEN, China, Oct. 29, 2020 /PRNewswire/ -- With the return from summer break, the continuation of COVID-Exit is much more prepared and planned, and elective surgery momentum has resumed. For physicians, safeguarding both patients, as well as themselves, is by far still the priority, especiall...
2020-10-30 10:57
1686
New Grant Program to Support Communities of Persons Affected by Leprosy During Coronavirus Pandemic Has Long-Term Goal of Strengthening Their Organizational Capacity
TOKYO, Oct. 29, 2020 /PRNewswire/ -- Sasakawa Leprosy (Hansen's Disease) Initiative will launch aUS$340,000 grant program on November 1 to support communities of persons affected by leprosy around the world that have been hard hit by the effects of the novel coronavirus. Through the program, whic...
2020-10-29 22:00
1515
Daewoong Pharmaceutical Partners with Tufts Medical Center for Phase 2 Clinical Trial with Niclosamide
SEOUL, South Korea, Oct. 29, 2020 /PRNewswire/ -- Daewoong Pharmaceutical (CEO Sengho Jeon, KRX: 069620) announced on October 26 that the collaborative clinical research agreement between Daewoong and Tufts Medical Center was signed to prepare for the phase 2 clinical study of DWRX2003 (active i...
2020-10-29 21:00
2283
Hyundai Bioscience: A Korean bio-tech solves the bioavailability issue of Niclosamide
SEOUL, South Korea, Oct. 29, 2020 /PRNewswire/ -- Expectations are increasing as a Korean bio-tech company has succeeded in solving the problem of low absorption which has been one of the biggest obstacles for the repositioning of Niclosamide, an anthelmintic, as the first orally ingested treatme...
2020-10-29 20:00
7471
Breathonix announces 60 secs, on-site, non-intrusive rapid breath test for COVID-19
SINGAPORE, Oct. 29, 2020 /PRNewswire/ -- Breathonix has developed a breath test to detect COVID-19 within a minute in-situ (on-site), achieving an accuracy above 90% at a recent pilot clinical trial involving 180 patients. BREATHONIX BREATHLYZER TECHNOLOGY The principle of the breath test is fun...
2020-10-29 17:22
1945
Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center
INCHEON, South Korea and SAN FRANCISCO, Oct. 28, 2020 /PRNewswire/ -- At a virtual ceremony today, Samsung Biologics (KRX: 207940.KS) announced the grand opening of its first US CDO R&D Center inSan Francisco, bringing its contract development services closer to global clients. As the "Next Door ...
2020-10-29 08:38
6659
Yuyu Pharma Announces the Introduction of Anti-Bribery Management System to meet Global Standards
SEOUL, South Korea, Oct. 28, 2020 /PRNewswire/ -- On October 28, 2020, Yuyu Pharm (CEO Robert Wonsang Yu, KRX 000220) initiated steps to incorporate ISO 37001 Anti-bribery management system to strengthen the company's compliance system. During the introduction ceremony of ISO 37001 held at Yuyu P...
2020-10-28 21:00
1828
Gracell Biotechnologies Raises $100 Million in Series C Funding to Advance Next Generation CAR-T Cell Therapies
SHANGHAI and SUZHOU, China, Oct. 28, 2020 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced it has secured$100 million i...
2020-10-28 21:00
2071
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 335 media titles]
2025-01-18 03:30
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 309 media titles]
2025-01-18 17:00
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 306 media titles]
2025-01-21 16:00
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 306 media titles]
2025-01-20 14:27
Supported by the Luxembourg Government, The Luxembourg House of Financial Technology (LHoFT) and the Asian Development Bank (ADB) Announce the 2nd Edition of Catapult | SE Asia 2025
[Picked up by 302 media titles]
2025-01-22 15:38
Most Read
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
2025-01-18 03:30
11066
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
2025-01-18 17:00
10032
Boosting Yeast Protein Production to Meet the Growing Global Demand for Alternative Proteins
2025-01-17 22:46
9507
Dongying's vibrant Spring Festival awaits visitors
2025-01-17 21:46
9397